Octreotide acetate
CAS No. | 79517-01-4 | Cat. No. | BCP04661 |
Name | Octreotide acetate | ||
Synonyms | Longastatin; Sandostatin; Longastatina; Samilstin; Sandostatina; Sandostatine; SMS 201995; | ||
Formula | C55H76N10O15S2 | M. Wt | 1181.39 |
Description | Octreotide acetate is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Octreotide acetate was approved as an injectable depot formulation for the treatment of acromegaly, gigantism, thyrotropinoma, diarrhea and flushing episodes associated with carcinoid syndrome, and diarrhea in patients with vasoactive intestinal peptide-secreting tumors. | ||
Pathways | GPCR/G Protein | ||
Targets | Somatostatin Receptor |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.